1. Home
  2. BHR vs NYXH Comparison

BHR vs NYXH Comparison

Compare BHR & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

N/A

Current Price

$2.29

Market Cap

159.3M

Sector

Real Estate

ML Signal

N/A

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.41

Market Cap

161.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHR
NYXH
Founded
2013
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
161.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BHR
NYXH
Price
$2.29
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
662.9K
180.7K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$1.26
52 Week High
$3.19
$8.59

Technical Indicators

Market Signals
Indicator
BHR
NYXH
Relative Strength Index (RSI) 61.20 28.03
Support Level $2.19 $1.26
Resistance Level $2.61 $1.70
Average True Range (ATR) 0.09 0.08
MACD 0.04 0.00
Stochastic Oscillator 97.14 4.82

Price Performance

Historical Comparison
BHR
NYXH

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: